טוען...

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

OBJECTIVES: To investigate the relationships between interferon alpha (IFNα) and the clinical and serological phenotype of patients with systemic autoimmune rheumatic disease (SARDs) in order to determine whether a distinct subpopulation of patients can be identified. METHODS: We recruited patients...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Arthritis Res Ther
Main Authors:	Reynolds, John A., Briggs, Tracy A., Rice, Gillian I., Darmalinggam, Sathya, Bondet, Vincent, Bruce, Ellen, Khan, Mumtaz, Haque, Sahena, Chinoy, Hector, Herrick, Ariane L., McCarthy, Eoghan M., Zeef, Leo, Hayes, Andrew, Duffy, Darragh, Parker, Ben, Bruce, Ian N.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BioMed Central 2019
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6567906/ https://ncbi.nlm.nih.gov/pubmed/31200750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1929-4
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

פריטים דומים